Issues & Advocacy

HOME > ADVOCACY

In This Section

Issues & Advocacy

SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.

LATEST NEWS

September 17, 2020 — SNMMI and Partners Host Congressional Briefing on the Groundbreaking Potential of Radiopharmaceuticals in Oncology and Need for Expanded Patient Access
Yesterday, SNMMI and its coalition partners, Medical Imaging & Technology Alliance (MITA) and Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) hosted a virtual briefing for Capitol Hill staff yesterday with leading physicians to discuss the extraordinary and growing impact of positron emission tomography (PET) and nuclear medicine in cancer treatment, as well as the importance of expanding patient access to these drugs through passage of the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (H.R. 3772).
August 11, 2020 — CMS extends the AUC Program Educational and Operations Testing Period through CY 2021
The Centers for Medicare and Medicaid Services (CMS) has provided an update regarding the Appropriate Use Criteria (AUC) Program established by The Protecting Access to Medicare Act (PAMA) of 2014.
August 4, 2020 — CMS Releases 2021 MPFS Proposed Rule
On August 3, CMS released the 2021 Medicare Physician Fee Schedule proposed rule. In this rule, CMS proposed changes to the payment provisions, introduced new coding structure for the evaluation and management codes and updated the Quality Payment Program.
July 29, 2020 — SNMMI Receives $750K Grant to Assist Nuclear Medicine Programs in Sub-Saharan Africa
The Department of Energy’s National Nuclear Security Administration (NNSA) has awarded SNMMI a grant for $750,000 over three years to support capacity building for nuclear medicine initiatives in sub-Saharan Africa.
July 23, 2020 — SNMMI and Coalition Partners Re-Engage Grassroots Efforts
On July 16, the Health Policy and Regulatory Affairs (HPRA) and Outreach departments co-hosted a patient advocacy webinar on how to be an effective patient advocate for H.R. 3772, the “Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019.”
July 10, 2020 — SNMMI Hosts FDA Townhall on the Impact of COVID-19
On Wednesday, June 17th, SNMMI hosted an FDA Townhall on the Impact of COVID-19 on regulatory activities.
June 18, 2020 — SNMMI and Coalition Partners Embrace Virtual Fly-Ins
Beginning in June, SNMMI and our Appropriate Payment Coalition Partners, the Medical Imaging Technology Alliance (MITA) and the Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) renewed their efforts to continue promoting H.R. 3772, the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019.
June 11, 2020 — SNMMI Requests Regulatory Relief for Training for Imaging and Localization Studies
Today, SNMMI along with ASNC, ASTRO and ACR requested regulatory relief for Training for imaging and localization studies during the COVID-19 Public Health Emergency.

Click For More Government Relations News